annual SGA:
$43.46M+$9.97M(+29.77%)Summary
- As of today (July 1, 2025), PTGX annual SGA is $43.46 million, with the most recent change of +$9.97 million (+29.77%) on December 31, 2024.
- During the last 3 years, PTGX annual SGA has risen by +$16.27 million (+59.81%).
- PTGX annual SGA is now at all-time high.
Performance
PTGX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$11.74M+$2.78M(+31.09%)Summary
- As of today (July 1, 2025), PTGX quarterly SGA is $11.74 million, with the most recent change of +$2.78 million (+31.09%) on March 1, 2025.
- Over the past year, PTGX quarterly SGA has dropped by -$3.17 million (-21.27%).
- PTGX quarterly SGA is now -21.27% below its all-time high of $14.91 million, reached on March 31, 2024.
Performance
PTGX quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
-$1.60B+$56.19M(+3.38%)Summary
- As of today (July 1, 2025), PTGX TTM SGA is -$1.60 billion, with the most recent change of +$56.19 million (+3.38%) on March 1, 2025.
- Over the past year, PTGX TTM SGA has dropped by -$1.64 billion (-4130.26%).
- PTGX TTM SGA is now -5750.16% below its all-time high of -$27.42 million.
Performance
PTGX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
PTGX Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +29.8% | -21.3% | -4130.3% |
| 3 y3 years | +59.8% | +11.6% | -5152.2% |
| 5 y5 years | +176.0% | +156.5% | -9604.5% |
PTGX Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +59.8% | -21.3% | +77.0% | at high | +34.2% |
| 5 y | 5-year | at high | +176.0% | -21.3% | +181.0% | -75.7% | +34.2% |
| alltime | all time | at high | +2236.7% | -21.3% | +2219.8% | -5750.2% | +34.2% |
PTGX Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $11.74M(+31.1%) | $40.29M(-7.3%) |
| Dec 2024 | $43.46M(+29.8%) | $8.95M(-11.9%) | $43.46M(+2.1%) |
| Sep 2024 | - | $10.16M(+7.6%) | $42.56M(+6.2%) |
| Jun 2024 | - | $9.44M(-36.7%) | $40.06M(+0.7%) |
| Mar 2024 | - | $14.91M(+85.2%) | $39.80M(+18.8%) |
| Dec 2023 | $33.49M(+5.5%) | $8.05M(+5.1%) | $33.49M(+4.4%) |
| Sep 2023 | - | $7.66M(-16.5%) | $32.07M(+2.4%) |
| Jun 2023 | - | $9.17M(+6.6%) | $31.31M(+5.0%) |
| Mar 2023 | - | $8.61M(+29.7%) | $29.83M(-6.0%) |
| Dec 2022 | $31.74M(+16.7%) | $6.63M(-3.9%) | $31.74M(-1.9%) |
| Sep 2022 | - | $6.90M(-10.3%) | $32.37M(-1.1%) |
| Jun 2022 | - | $7.69M(-26.9%) | $32.72M(+3.1%) |
| Mar 2022 | - | $10.52M(+44.8%) | $31.75M(+16.7%) |
| Dec 2021 | $27.20M(+45.9%) | $7.26M(+0.1%) | $27.20M(+9.1%) |
| Sep 2021 | - | $7.26M(+8.1%) | $24.93M(+10.5%) |
| Jun 2021 | - | $6.71M(+12.6%) | $22.57M(+12.7%) |
| Mar 2021 | - | $5.96M(+19.4%) | $20.03M(+7.5%) |
| Dec 2020 | $18.64M(+18.3%) | $4.99M(+2.1%) | $18.64M(+5.0%) |
| Sep 2020 | - | $4.89M(+17.1%) | $17.75M(+5.2%) |
| Jun 2020 | - | $4.18M(-8.7%) | $16.88M(+1.9%) |
| Mar 2020 | - | $4.58M(+11.4%) | $16.56M(+5.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $15.75M(+15.0%) | $4.11M(+2.3%) | $15.75M(+3.9%) |
| Sep 2019 | - | $4.01M(+3.9%) | $15.16M(+4.5%) |
| Jun 2019 | - | $3.86M(+2.6%) | $14.51M(+5.0%) |
| Mar 2019 | - | $3.76M(+7.0%) | $13.82M(+0.9%) |
| Dec 2018 | $13.70M(+16.3%) | $3.52M(+4.6%) | $13.70M(+3.4%) |
| Sep 2018 | - | $3.36M(+5.8%) | $13.25M(+6.2%) |
| Jun 2018 | - | $3.18M(-12.7%) | $12.48M(+0.4%) |
| Mar 2018 | - | $3.64M(+18.6%) | $12.43M(+5.5%) |
| Dec 2017 | $11.78M(+69.2%) | $3.07M(+18.4%) | $11.78M(+4.4%) |
| Sep 2017 | - | $2.59M(-17.0%) | $11.28M(+9.9%) |
| Jun 2017 | - | $3.12M(+4.4%) | $10.27M(+20.3%) |
| Mar 2017 | - | $2.99M(+16.2%) | $8.54M(+22.6%) |
| Dec 2016 | $6.96M(+134.9%) | $2.57M(+63.2%) | $6.96M(+34.0%) |
| Sep 2016 | - | $1.58M(+13.0%) | $5.20M(+15.9%) |
| Jun 2016 | - | $1.40M(-1.4%) | $4.48M(+15.7%) |
| Mar 2016 | - | $1.42M(+75.1%) | $3.87M(+30.7%) |
| Dec 2015 | $2.96M(+59.3%) | $808.00K(-6.4%) | $2.96M(+37.5%) |
| Sep 2015 | - | $863.00K(+9.8%) | $2.15M(+66.8%) |
| Jun 2015 | - | $786.00K(+55.3%) | $1.29M(+155.3%) |
| Mar 2015 | - | $506.00K | $506.00K |
| Dec 2014 | $1.86M | - | - |
FAQ
- What is Protagonist Therapeutics annual SGA?
- What is the all time high annual SGA for Protagonist Therapeutics?
- What is Protagonist Therapeutics annual SGA year-on-year change?
- What is Protagonist Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly SGA year-on-year change?
- What is Protagonist Therapeutics TTM SGA?
- What is the all time high TTM SGA for Protagonist Therapeutics?
- What is Protagonist Therapeutics TTM SGA year-on-year change?
What is Protagonist Therapeutics annual SGA?
The current annual SGA of PTGX is $43.46M
What is the all time high annual SGA for Protagonist Therapeutics?
Protagonist Therapeutics all-time high annual SGA is $43.46M
What is Protagonist Therapeutics annual SGA year-on-year change?
Over the past year, PTGX annual SGA has changed by +$9.97M (+29.77%)
What is Protagonist Therapeutics quarterly SGA?
The current quarterly SGA of PTGX is $11.74M
What is the all time high quarterly SGA for Protagonist Therapeutics?
Protagonist Therapeutics all-time high quarterly SGA is $14.91M
What is Protagonist Therapeutics quarterly SGA year-on-year change?
Over the past year, PTGX quarterly SGA has changed by -$3.17M (-21.27%)
What is Protagonist Therapeutics TTM SGA?
The current TTM SGA of PTGX is -$1.60B
What is the all time high TTM SGA for Protagonist Therapeutics?
Protagonist Therapeutics all-time high TTM SGA is -$27.42M
What is Protagonist Therapeutics TTM SGA year-on-year change?
Over the past year, PTGX TTM SGA has changed by -$1.64B (-4130.26%)